{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:42:23Z","timestamp":1648536143661},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11606-014-3173-6","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T14:07:46Z","timestamp":1422281266000},"page":"860-863","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exercises In Clinical Reasoning"],"prefix":"10.1007","volume":"30","author":[{"given":"Urvi A.","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Abourjaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Rencic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"3173_CR1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1365-2923.2007.02911.x","volume":"41","author":"NN Woods","year":"2007","unstructured":"Woods NN. Science is fundamental: the role of biomedical knowledge in clinical reasoning. Med Educ. 2007;41:1173\u20137.","journal-title":"Med Educ"},{"key":"3173_CR2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2929.2004.01972.x","volume":"39","author":"KW Eva","year":"2005","unstructured":"Eva KW. What every teacher needs to know about clinical reasoning. Med Educ. 2005;39:98\u2013106.","journal-title":"Med Educ"},{"key":"3173_CR3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00426-010-0281-8","volume":"74","author":"S Mamede","year":"2010","unstructured":"Mamede S, Schmidt HG, Rikers RM, Custers EJ, Splinter TA, van Saase JL. Conscious thought beats deliberation without attention in diagnostic decision-making: at least when you are an expert. Psychol Res. 2010;74:586\u201392.","journal-title":"Psychol Res"},{"key":"3173_CR4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2710.2008.00943.x","volume":"33","author":"JF Knudsen","year":"2008","unstructured":"Knudsen JF, Sokol GH, Flowers CM. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy. J Clin Pharm Ther. 2008;33:513\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"3173_CR5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1212\/WNL.55.1.150","volume":"55","author":"SB Zachariah","year":"2000","unstructured":"Zachariah SB, Zachariah A, Ananda R, Stewart JT. Hypothermia and thermoregulatory derangements induced by valproic acid. Neurology. 2000;55:150\u20131.","journal-title":"Neurology"},{"key":"3173_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0893-133X(00)00243-8","volume":"24","author":"SC Stout","year":"2001","unstructured":"Stout SC, Owens MJ, Lindsey KP, Knight DL, Nemeroff CB. Effects of sodium valproate on corticotropin-releasing factor systems in rat brain. Neuropsychopharmacology. 2001;24:624\u201331.","journal-title":"Neuropsychopharmacology"},{"key":"3173_CR7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/jpet.102.045419","volume":"305","author":"ML Gilmor","year":"2003","unstructured":"Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. J Pharmacol Exp Ther. 2003;305:434\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"3173_CR8","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1523\/JNEUROSCI.15-10-06340.1995","volume":"15","author":"DT Chalmers","year":"1995","unstructured":"Chalmers DT, Lovenberg TW, De Souza EB. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci. 1995;15:6340\u201350.","journal-title":"J Neurosci"},{"key":"3173_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3122\/jabfm.2007.05.070062","volume":"20","author":"J Wadzinski","year":"2007","unstructured":"Wadzinski J, Franks R, Roane D, Bayard M. Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med. 2007;20:499\u2013502.","journal-title":"J Am Board Fam Med"},{"key":"3173_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.eplepsyres.2012.04.001","volume":"101","author":"Y Yamamoto","year":"2012","unstructured":"Yamamoto Y, Takahashi Y, Suzuki E, et al. Risk factors for hyperammonemia associated with valproic acid therapy in adult epilepsy patients. Epilepsy Res. 2012;101:202\u20139.","journal-title":"Epilepsy Res"},{"key":"3173_CR11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.1983.tb03428.x","volume":"24","author":"JM Warter","year":"1983","unstructured":"Warter JM, Marescaux C, Brandt C, et al. Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans. Epilepsia. 1983;24:628\u201333.","journal-title":"Epilepsia"},{"key":"3173_CR12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.yebeh.2011.05.006","volume":"21","author":"A Gomez-Ibanez","year":"2011","unstructured":"Gomez-Ibanez A, Urrestarazu-Bolumburu E, Viteri-Torres C. Hyperammonemic encephalopathy related to valproate, phenobarbital, and topiramate synergism. Epilepsy Behav. 2011;21:480\u20132.","journal-title":"Epilepsy Behav"},{"key":"3173_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2146\/ajhp110049","volume":"69","author":"CM Mock","year":"2012","unstructured":"Mock CM, Schwetschenau KH. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy. Am J Health Syst Pharm. 2012;69:35\u20139.","journal-title":"Am J Health Syst Pharm"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-014-3173-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-014-3173-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-014-3173-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:18:34Z","timestamp":1566260314000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-014-3173-6"}},"subtitle":["A Confusing Interaction"],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3173"],"URL":"https:\/\/doi.org\/10.1007\/s11606-014-3173-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]}}}